Arrhythmic disorder mapped to chromosome 1q42-q43 causes malignant polymorphic ventricular tachycardia in structurally normal hearts
- PMID: 10588221
- DOI: 10.1016/s0735-1097(99)00461-1
Arrhythmic disorder mapped to chromosome 1q42-q43 causes malignant polymorphic ventricular tachycardia in structurally normal hearts
Abstract
Objectives: The purpose of this study was to provide clinical and anatomical characteristics as well as genetic background of a malignant arrhythmogenic disorder.
Background: An inherited autosomally dominant cardiac syndrome causing stress-induced polymorphic ventricular tachycardia and syncope in the absence of structural myocardial changes was detected in two families.
Methods: Two unrelated families with six victims of sudden death and 51 living members were evaluated. Resting and exercise electrocardiograms (ECG), echocardiography, magnetic resonance imaging (MRI), cineangiography, microscopic examination of endomyocardial biopsies and a drug testing with a class IC antiarrhythmic agent flecainide were performed. A genetic linkage analysis was carried out to map the gene locus.
Results: Of the 24 affected individuals, 10 had succumbed with six cases of sudden death, and 14 survivors showed evidence of disease. Exercise stress test induced ventricular bigeminy or polymorphic ventricular tachycardia in affected individuals. Three children initially examined before 10 years of age developed arrhythmias during a four-year follow-up. Resting ECGs were normal in affected subjects except a slight prolongation of the QT intervals adjusted for heart rate (QTc) (430 +/- 18 vs. 409 +/- 19 ms, affected vs. nonaffected, p < 0.01). Administration of flecainide did not induce ECG abnormalities encountered in familial idiopathic ventricular fibrillation. Ventricular volumes, contractility and wall measurements were normal by echocardiography, right ventricular cineangiography and MRI. Histopathological examination showed no fibrosis or fatty infiltration. The cumulative cardiac mortality by the age of 30 years was 31%. The disease locus was assigned to chromosome 1q42-q43, with a maximal pairwise lod score of 4.74 in the two families combined. Only one heterozygous carrier was clinically unaffected suggesting high disease penetrance in adulthood.
Conclusions: A distinct cardiac disorder linked to chromosome 1q42-q43 causes exercise-induced polymorphic ventricular tachycardia in structurally normal hearts and is highly malignant. Delayed clinical manifestation necessitates repeated exercise electrocardiography to assure diagnosis in young individuals of the families.
Similar articles
-
Familial effort polymorphic ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy map to chromosome 1q42-43.Am J Cardiol. 2000 Mar 1;85(5):573-9. doi: 10.1016/s0002-9149(99)00814-0. Am J Cardiol. 2000. PMID: 11078270
-
Autosomal recessive catecholamine- or exercise-induced polymorphic ventricular tachycardia: clinical features and assignment of the disease gene to chromosome 1p13-21.Circulation. 2001 Jun 12;103(23):2822-7. doi: 10.1161/01.cir.103.23.2822. Circulation. 2001. PMID: 11401939
-
Familial polymorphic ventricular arrhythmias: a quarter century of successful medical treatment based on serial exercise-pharmacologic testing.J Am Coll Cardiol. 1999 Dec;34(7):2015-22. doi: 10.1016/s0735-1097(99)00438-6. J Am Coll Cardiol. 1999. PMID: 10588218
-
Genes, exercise and sudden death: molecular basis of familial catecholaminergic polymorphic ventricular tachycardia.Ann Med. 2004;36 Suppl 1:81-6. doi: 10.1080/17431380410032599. Ann Med. 2004. PMID: 15176428 Review.
-
[Arrhythmogenic right ventricular disease].Z Kardiol. 1994;83 Suppl 6:175-80. Z Kardiol. 1994. PMID: 7863692 Review. German.
Cited by
-
Role of Ca2+ in healthy and pathologic cardiac function: from normal excitation-contraction coupling to mutations that cause inherited arrhythmia.Arch Toxicol. 2023 Jan;97(1):73-92. doi: 10.1007/s00204-022-03385-0. Epub 2022 Oct 10. Arch Toxicol. 2023. PMID: 36214829 Free PMC article. Review.
-
JCS/JHRS 2022 Guideline on Diagnosis and Risk Assessment of Arrhythmia.J Arrhythm. 2024 Jun 12;40(4):655-752. doi: 10.1002/joa3.13052. eCollection 2024 Aug. J Arrhythm. 2024. PMID: 39139890 Free PMC article. No abstract available.
-
Cellular mechanisms underlying the development of catecholaminergic ventricular tachycardia.Circulation. 2005 May 31;111(21):2727-33. doi: 10.1161/CIRCULATIONAHA.104.479295. Epub 2005 May 23. Circulation. 2005. PMID: 15911700 Free PMC article.
-
Impact of Mendelian inheritance in cardiovascular disease.Ann N Y Acad Sci. 2010 Dec;1214:122-37. doi: 10.1111/j.1749-6632.2010.05791.x. Epub 2010 Oct 19. Ann N Y Acad Sci. 2010. PMID: 20958326 Free PMC article. Review.
-
The RYR2-encoded ryanodine receptor/calcium release channel in patients diagnosed previously with either catecholaminergic polymorphic ventricular tachycardia or genotype negative, exercise-induced long QT syndrome: a comprehensive open reading frame mutational analysis.J Am Coll Cardiol. 2009 Nov 24;54(22):2065-74. doi: 10.1016/j.jacc.2009.08.022. J Am Coll Cardiol. 2009. PMID: 19926015 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources